When the coronavirus pandemic began, the challenge for Pfizer and BioNTech wasn't just developing a Covid-19 vaccine -- they also had to make it, and by the hundreds of millions.
//google call
When the coronavirus pandemic began, the challenge for Pfizer and BioNTech wasn't just developing a Covid-19 vaccine -- they also had to make it, and by the hundreds of millions.
0 comments:
Post a Comment